Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The DEPT OF DEFENSE | DEPT OF THE ARMY has issued a Tender notice for the procurement of a Agnostic Metagenomic Nextgeneration Sequencing Mngs for Clinical Diagnostics in the USA. This Tender notice was published on 16 May 2026 and is scheduled to close on 22 May 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 141395492, while the tender notice number is W911SR-26-R-MNGS and Registering on the platform.
Procurement Summary
Country: USA
Summary: Agnostic Metagenomic Nextgeneration Sequencing Mngs for Clinical Diagnostics
Deadline: 22 May 2026
Posting Date: 16 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141395492
Document Ref. No.: W911SR-26-R-MNGS
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details Tender Details DISCLAIMER Documents
This is an information request only. This request is issued solely for information and planning purposes - it does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. Solicitations are not available currently. This notice does not constitute a commitment by the United States Government to contract for any supply or service whatsoever.
Purpose:
The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) invites you to collaborate on a critical mission: to develop a field-forward, threat-agnostic metagenomic next-generation sequencing (mNGS) capability for rapid identification of traditional, novel, emerging, and engineered infectious disease agents. This initiative seeks to address a critical gap in the current diagnostic portfolio by enabling hypothesis-free identification of pathogens that may be undetectable by standard targeted assays.
This RFI is your opportunity to help shape the future of military medical diagnostics and contribute directly to the health, readiness, and resilience of our Armed Forces in diverse operational environments.
This initiative is a critical component of a Medical Readiness and Response capability. Potential technologies will directly support Formation Based Layered Protection. By enabling early and accurate characterization of pathogens, agnostic metagenomic next-generation sequencing (mNGS) clinical diagnostics capability will help the Joint Force avoid being understood by disrupting adversary capabilities to identify, locate, and target. By enabling appropriate and timely treatment, they will help the warfighter avoid being hit and ensure they can survive if hit or attacked to sustain and regenerate combat power.
Requested Information of Interest:
CPE CBRND is conducting essential market research for a new initiative dedicated to identifying and advancing mature, portable, and integrated mNGS systems for clinical diagnost...
Notice ID: w911sr-26-r-mngs
Department/Ind. Agency: dept of defense
Sub-tier: dept of the army
Office: w6qk acc-apg
Inactive Dates: jun 06, 2026
Inactive Policy: 15 days after response date
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google